Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit

One daysingle sourceOne outlet reported this, once - no second voice in this corpus.

After publishing: 1 URL changed1 change

prnewswire.comseen 3 Sept, 17:32URL changed
now resolves towww.prnewswire.com:443/news-releases/aardvark-therapeutics-inc-aard-investors-with-substantial-losses-have-opportunity-to-lead-aardvark-class-action-lawsuit-302860950.html

All 1 reports on Wed, 26 August 2026

What it is about

Reed Kathrein Hagens Berman Prnewswire Hagens Berman Sobol Shapiro Hagens Berman Sobol Shapiro Drug Administration Nasdaq

Who published it, and when

How it spread - 1 original report

Wed, 26 August 2026
1 report
- prnewswire.com21:58first to report
  Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit
  URL changednow www.prnewswire.com:443/news-releases/aardvark-therapeutics-inc-aard-investors-with-substantial-losses-have-opportunity-to-lead-aardvark-class-action-lawsuit-302860950.html
  /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, a national shareholder rights firm, notifies investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) of a...